LAURA PHILLIPS: Open Payments
NPI 1497716708 · CHAPEL HILL, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,355 in 108 payments from 19 companies in 2025. Trend: 2023 $2,050 · 2024 $2,471 · 2025 $2,355
Food & beverage: $2,355
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $264 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $257 |
| Novartis Pharmaceuticals Corporation | 11 | $217 |
| UCB, Inc. | 6 | $208 |
| ABBVIE INC. | 10 | $204 |
| Regeneron Healthcare Solutions, Inc. | 10 | $153 |
| Galderma Laboratories, L.P. | 10 | $146 |
| GENZYME CORPORATION | 6 | $135 |
| Lilly USA, LLC | 1 | $114 |
| LEO Pharma Inc. | 4 | $105 |
Products named: DUPIXENT, Bimzelx, OTEZLA, COSENTYX, NEMLUVIO, EBGLYSS, RINVOQ, ILUMYA.
Industry payments across NC — which companies pay providers there.
